Announcements

The George Washington University (GW) Medical Faculty Associates (GW MFA), is pleased to announce the appointment of Christopher T. Smedley, MPM, as the Chief Clinical Affairs and Strategy Officer. Smedley served as a consultant in this role, and officially transitioned into the position on May 1,…
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) and Pfizer Global Medical Grants are collaborating to offer a grant opportunity focused on broad implementation of GW’s Teledermatology Help Desk Clinic model in underserved areas across the United States.
The GW School of Medicine and Health Sciences (GW SMHS) and the GW Medical Faculty Associates (GW MFA) are pleased to announce that Daniel Stein, MD, MHS, will serve as the interim chair of the GW Department of Urology.
Joyce Maring, DPT, EdD, chair of the Department of Health, Human Function, and Rehabilitation Sciences since 2013, will transition into a new role on July 1, 2023, to serve as the Executive Associate Dean for Health Sciences. Ellen Costello, PT, PhD, professor in the Department of Health, Human…
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) and the GW Medical Faculty Associates (GW MFA) are pleased to announce the appointment of Professor David A. Belyea, MD, MBA, FAAO, FACS, as the fifth chair of the GW Department of Ophthalmology. With this…
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) announced the selection of Hematology and Oncology Fellows, Walaa Aldhahri, MBBS, and Zoë McKinnell, MD, as the 2023 Albert L. Tucker and Elizabeth T. Tucker Postdoctoral Fellowship awardees.
The George Washington University School of Medicine and Health Sciences faculty promotion and/or tenure list and the members of the Class of 2023 Emeriti Faculty.
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) is pleased to announce that Stephanie Sarandos, MA, has been selected to serve as the assistant dean for evaluation. In this role, Sarandos will be responsible for all aspects of MD program evaluation, ensuring the…
Pfizer has launched a Phase 3 study of its RSV vaccine candidate and researchers at the George Washington University are studying the vaccine’s safety and ability to trigger an immune response in two groups of people at risk for severe illness caused by respiratory syncytial virus or RSV.
As of 2021 it is estimated that world-wide the number of refugees and asylum-seekers is over 31 million. While academics and researchers have been attempting to capture global and domestic attitudes towards these vulnerable groups, many of these studies will report biased findings and influence…